Founded in 2023, CardiaMetrics is based in Grenoble, a true hub of research and innovation, and in Caen, the birthplace of cardiac telemonitoring in France. CardiaMetrics benefits from the dynamism of these two complementary ecosystems. Together, the four co-founders aim to address the challenges of scaling telemonitoring for chronic diseases. They are determined to place “health as a service” at the heart of their project, focusing on providing both practical and impactful innovations for patients and caregivers.
The company is also build on the material and immaterial assets developed during Dr. Cindy Michel’s Ph.D while working at SentinHealth. These assets have allowed the company to directly enter the clinical stage and plan the first trials for the beginning of 2025.
Executive committee
Thibault Parmentier
CEO & co-founder
Rowing brought me to Grenoble, where I completed my studies with a PhD in Artificial Intelligence, focusing on knowledge representation. Like a true Grenoblois, R&D and IT were my main fields of interest for 15 years before embracing health through prevention with EIT Health.
I met Mathieu while managing the Grenoble branch of the service company Viseo, and later I discovered Cindy and the Medtech startup world as CTO & COO at SentinHealth. All together, with Rémi, we decided to found CardiaMetrics, each of us contributing our perspective to help address the challenges of aging and dependency.
Cindy Michel
CSO & co-founder
Passionate about physiology, I first studied biology before specializing in medical device engineering. My growing interest in cardiology led me to Brisbane, where I became aware of the magnitude of the challenges related to heart failure.
After my studies, I had the opportunity to join a start-up in its early stages, where I conducted a thesis on an innovative implantable medical device. I not only contributed to research but also to product development and team management, thus blending science and entrepreneurship.
Committed to providing patients and healthcare systems with innovative solutions for aging well at home and easing the mental burden of managing chronic conditions, I co-founded CardiaMetrics.
Today, as the scientific director, I passionately continue the mission of transforming heart failure management by offering technological alternatives to as many people as possible.
Rémi Sabatier
CMO & co-founder
Interventional cardiologist at CHU de Caen Normandie, specialized since 2005 in medical telemonitoring and an active contributor to its integration into mainstream healthcare in France. I am, in search of solutions providing reliable data to remotely manage my patients.
I saw in CardiaMetrics a great opportunity to bring my expertise and network to an exciting project and to directly contribute to the emergence of a relevant and effective solution.
Mathieu Ruhlmann
CTO & co-founder
With 20 years of experience in software development, where I had the opportunity to work on a wide variety of projects and scopes, tackle complex data management issues, and closely follow major technological advances such as artificial intelligence, I was eager to join the founding team of CardiaMetrics to take on a new challenge that is not only technological and human, but also meaningful for our society.
The proximity of my family environment to the health field made me aware of the many challenges our healthcare system faces today. I am convinced that the project we are pursuing will be beneficial for patients while easing the pressure on the healthcare system, which is why I will put all my energy into developing our product so that it can reach the market.
Cécilia Kroiss
COO
With extensive experience in the medical device industry, I specialize in managing the development of electro-medical, implantable, and software devices.
Graduated in Technology and Innovation Management from Grenoble École de Management and in biomechanics engineering from ISIFC, I have taken on leadership roles in medical companies from startups to large international groups.
I am thrilled and ambitious to join CardiaMetrics to succeed in bringing technology to serve the health of patients living with heart failure.
Medical and scientific board
Pr François Roubille
Cardiologist & Investor
Clinical Role
-
Pr François Roubille is a French cardiologist and senior clinical researcher working at CHU de Montpellier – Hôpital Arnaud de Villeneuve in France. He specializes in heart failure, acute cardiac care, and cardiovascular medicine.
-
He serves as a Praticien Hospitalier in the Cardiology Department at CHU de Montpellier.
-
He is responsible for the heart failure medical team, focusing on advanced cardiovascular care and critical cardiology.
Academic and Scientific Engagement
-
Pr Roubille is involved in international cardiology communities, including sessions and presentations with the European Society of Cardiology (ESC), especially in acute cardiovascular care and heart failure topics.
-
He has participated in expert discussions and contributed to European clinical consensus documents within cardiology.
Research Contributions
-
Pr Roubille is involved in international cardiology communities, including sessions and presentations with the European Society of Cardiology (ESC), especially in acute cardiovascular care and heart failure topics.
-
He has participated in expert discussions and contributed to European clinical consensus documents within cardiology.
Clinical Role
- Pr Michael R. Zile, M.D., is a highly respected cardiologist based in the United States. He serves as the Charles Ezra Daniel Professor of Medicine and is a Distinguished University Professor at the Medical University of South Carolina (MUSC) in Charleston, where he specializes in heart failure, cardiac function, and valvular heart disease. He also practices cardiology at the Ralph H. Johnson VA Medical Center and contributes to patient care in heart failure, adult congenital heart disease, and transplant cardiology.
- Prof. Zile completed his medical training at Rush University School of Medicine and pursued cardiology fellowships at Tufts-New England Medical Center and the VA Medical Center in Boston.
Academic and Scientific Engagement
- Pr Zile is deeply involved in academic cardiology and research. He holds leadership roles in multiple professional societies and has served on editorial boards for major cardiovascular journals such as the Journal of the American College of Cardiology and Circulation. He is also active in societies including the American Heart Association, American College of Cardiology, Heart Failure Society of America, and others.
- In addition to his primary roles at MUSC, he is an adjunct professor of bioengineering at Clemson University, reflecting an interdisciplinary focus on both clinical and translational science.
Research Contributions
- Pr Zile has a robust research career spanning basic, translational, and clinical cardiology. His work focuses on mechanisms of heart failure development and progression, aiming to translate fundamental insights into improved diagnostic and treatment methods. His research has been supported by grants from major institutions including the National Heart, Lung, and Blood Institute, the American Heart Association, and the U.S. Department of Veterans Affairs.
- He is also an author or co-author on hundreds of peer-reviewed publications covering topics such as diastolic dysfunction, chronic heart failure, cardiac biomechanics, therapeutic strategies, and cardiovascular outcomes, and his work is widely cited in leading journals.
- Pr Zile’s contributions have earned recognition including the William S. Middleton Award for Outstanding Achievement in Biomedical Research and the South Carolina Governor’s Award for Excellence in Scientific Research.
Pr Michael Robert Zile
Cardiologist
Pr Maurizio Volterrani
Cardiologist
Clinical Role
-
Pr Maurizio Volterrani is a leading Italian cardiologist who serves as Head of the Cardiorespiratory Area / Cardiology Department at IRCCS San Raffaele Roma — a major research and clinical institute in Rome, Italy.
-
He is widely recognized for clinical expertise in heart failure, cardiac rehabilitation, exercise physiology, telemedicine, and e-health approaches to chronic cardiovascular disease.
Academic and Scientific Engagement
Pr Volterrani holds academic appointments and plays a major role in European cardiology networks:
-
Adjunct Professor, University of Rome “Tor Vergata,” Faculty of Medicine, Cardiovascular Diseases Discipline.
-
Director & Professor, Cardio-Pulmonary Departments at IRCCS San Raffaele Roma.
-
Active member and leader within the Heart Failure Association (HFA) of the European Society of Cardiology (ESC), including roles in exercise physiology, telemonitoring, digital health, and quality-of-care initiatives.
-
Contributor to ESC congresses and sessions focused on chronic heart failure, treatment strategies, patient profiling, and advanced clinical care topics.
Pr Volterrani has also served on editorial boards and as a reviewer for many leading cardiology journals, including JACC, European Journal of Heart Failure, and others — reflecting his broad academic standing.
Research Contributions
Pr Volterrani is a prolific researcher with an extensive scientific output:
-
Author of 400+ publications in peer-reviewed cardiovascular journals and clinical reports.
-
His recent work includes high-impact contributions such as “Implementation of guideline-recommended medical therapy for patients with heart failure in Europe”, published in ESC Heart Failure — a collaborative European review addressing optimal heart failure treatment strategies.
-
Research interests span heart failure treatment optimization, cardiac rehabilitation interventions, telemedicine and digital health applications for cardiology, and the clinical implementation of guideline-based care.
-
Pr Volterrani’s academic influence extends internationally through ongoing collaborations, participation in ESC-linked task forces, guideline committees, and registry/epidemiology projects in heart failure.
His leadership in both clinical trials and guideline-related work positions him among Europe’s most respected voices in contemporary heart failure research and care.
Clinical Role
-
Dr Danielle Nusimovici-Avadis is a seasoned clinical, regulatory, and quality expert in the medical device and health technology sector. She serves as the CEO & Founder of MedTech SMEs, a consultancy specializing in clinical strategy, regulatory affairs, clinical evaluations, and market access for medical devices.
-
In her professional role, Danielle advises medical technology organisations on clinical development strategy, regulatory compliance, quality systems, clinical evidence generation, and due diligence audits — bridging technical execution and clinical requirements to optimise product pathways from R&D through global submission readiness.
Academic and Scientific Engagement
-
Dr Nusimovici-Avadis holds a Ph.D. and has a strong academic background, including summa cum laude MD thesis work at Louis Pasteur University, Strasbourg earlier in her career.
-
Her academic experience encompasses medical sciences, clinical research methodologies, and regulatory strategy. This background enhances her expertise in shaping evidence generation plans and clinical evaluation frameworks for medical technologies such as implantable devices and diagnostic platforms.
Research Contributions
-
Dr Nusimovici-Avadis holds a Ph.D. and has a strong academic background, including summa cum laude MD thesis work at Louis Pasteur University, Strasbourg earlier in her career.
-
Her academic experience encompasses medical sciences, clinical research methodologies, and regulatory strategy. This background enhances her expertise in shaping evidence generation plans and clinical evaluation frameworks for medical technologies such as implantable devices and diagnostic platforms.
Danielle Nusimovici-Avadis Ph.D
Regulatory expert
Strategic committee
Thibault Parmentier, PhD
Chairman & cofounder
Cindy Michel, PhD
Cofounder
Karim Gacem, MD
Cardiologist
Bertrand Caillard